Study title: Monitoring markers of survivor beta cell function and stress in recently diagnosed type 1 diabetes
Is your child interested in participating in a research study on type 1 diabetes?

Dr. Peter Thompson and Dr. Brandy Wicklow are conducting a research study to measure markers of the remaining insulin-producing beta cells in the first 5 years after diagnosis of type 1 diabetes in children and teens at the Children’s Hospital Research Institute of Manitoba and Health Sciences Centre in Winnipeg.
The ‘survivor’ beta cells send out marker signals akin to an S.O.S. distress call. These markers are detectable in blood and can provide useful information about the beta cell’s functional status and stress level. A better understanding of ‘survivor’ beta cells may reveal important clues as to how type 1 diabetes progresses after diagnosis and offer insights that will help us improve glycemic control in recently diagnosed individuals.
If you are interested and would like more information, please fill out the Consent to Contact Form and email the form to dochulor@chrim.ca. A member of the study team will be in contact with you once the form has been received.
What's New


FARHA Inc. Research Podcast S1E1


4 DREAM Researchers Receive Funding from CHRIM Operating Grants


New Publication from the Thompson Lab!


2 New Publications from the Saleem Lab!


asPERusual Podcast: Kick off to engaging children, youth and families in research

